{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:18:33Z","timestamp":1790259513673,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.metabol.2021.154801","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T04:14:08Z","timestamp":1622175248000},"page":"154801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1"],"prefix":"10.1016","volume":"121","author":[{"given":"Raghd Abu","family":"Helal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda E.","family":"Ghadieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison T.","family":"Muturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Asalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Gatto-Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154801_bb0005","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154801_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2021.154801_bb0015","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154801_bb0020","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jhep.2014.07.024","article-title":"Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent","volume":"61","author":"Gan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2021.154801_bb0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jhep.2011.05.019","article-title":"Lipotoxicity in NASH","volume":"56","author":"Fuchs","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2021.154801_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010436","article-title":"Immunity as cornerstone of non-alcoholic fatty liver disease: the contribution of oxidative stress in the disease progression","volume":"22","author":"Dallio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154801_bb0035","doi-asserted-by":"crossref","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.metabol.2021.154801_bb0040","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/js.2019-00065","article-title":"Hyperinsulinemia: an early indicator of metabolic dysfunction","volume":"3","author":"Thomas","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.metabol.2021.154801_bb0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.metabol.2021.154801_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2021.154801_bb0055","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/hep.26988","article-title":"Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis","volume":"59","author":"Bril","year":"2014","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154801_bb0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fendo.2017.00054","article-title":"Reduced hepatic carcinoembryonic antigen-related cell adhesion molecule 1 level in obesity","volume":"8","author":"Heinrich","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2021.154801_bb0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1746-1596-6-40","article-title":"The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes","volume":"6","author":"Lee","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.metabol.2021.154801_bb0070","first-page":"198","article-title":"Hepatic insulin clearance: mechanism and physiology","volume":"34","author":"Najjar","year":"2019","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.metabol.2021.154801_bb0075","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1210\/en.2008-1439","article-title":"Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance","volume":"150","author":"Xu","year":"2009","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154801_bb0080","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.2337\/db08-0379","article-title":"Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism","volume":"57","author":"DeAngelis","year":"2008","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154801_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2019.01.008","article-title":"Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis","volume":"93","author":"Ghadieh","year":"2019","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154801_bb0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ng840","article-title":"CEACAM1 regulates insulin clearance in liver","volume":"30","author":"Poy","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2021.154801_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2005.06.001","article-title":"Insulin acutely decreases hepatic fatty acid synthase activity","volume":"2","author":"Najjar","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154801_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00281-013-0407-3","article-title":"CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)","volume":"36","author":"Najjar","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.metabol.2021.154801_bb0105","doi-asserted-by":"crossref","first-page":"E519","DOI":"10.1152\/ajpendo.00266.2013","article-title":"Ceacam1 deletion causes vascular alterations in large vessels","volume":"305","author":"Najjar","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154801_bb0110","first-page":"69","article-title":"Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis","volume":"2010","author":"Ghosh","year":"2010","journal-title":"Hepat Med"},{"key":"10.1016\/j.metabol.2021.154801_bb0115","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hep4.1590","article-title":"Loss of hepatic carcinoembryonic antigen-related cell adhesion molecule 1 links nonalcoholic steatohepatitis to atherosclerosis","volume":"4","author":"Ghadieh","year":"2020","journal-title":"Int Hepatol Commun"},{"key":"10.1016\/j.metabol.2021.154801_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103110","article-title":"CEACAM1 in liver injury, metabolic and immune regulation","volume":"19","author":"Horst","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154801_bb0125","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s00125-017-4432-y","article-title":"Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice","volume":"60","author":"Russo","year":"2017","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2021.154801_bb0130","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.2337\/db14-1772","article-title":"Forced hepatic overexpression of CEACAM1 curtails diet-induced insulin resistance","volume":"64","author":"Al-Share","year":"2015","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154801_bb0135","first-page":"189","article-title":"A comparison of Brunt\u2019s Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a proposed NAS scoring that includes fibrosis in non-alcoholic fatty liver disease staging","volume":"34","author":"Santiago-Rolon","year":"2015","journal-title":"P R Health Sci J"},{"key":"10.1016\/j.metabol.2021.154801_bb0140","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2021.154801_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fimmu.2019.00433","article-title":"Signaling crosstalk mechanisms that may fine-tune pathogen-responsive NFkappaB","volume":"10","author":"Adelaja","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2021.154801_bb0150","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fphar.2017.00798","article-title":"NF-kappabeta: a potential target in the management of vascular complications of diabetes","volume":"8","author":"Suryavanshi","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2021.154801_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.metabol.2021.154801_bb0160","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bcp.2004.06.003","article-title":"Determination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter","volume":"68","author":"Abdel-Razzak","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2021.154801_bb0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis","volume":"4","author":"Mari","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154801_bb0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154801_bb0175","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.4049\/jimmunol.176.11.6709","article-title":"Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL","volume":"176","author":"Manicassamy","year":"2006","journal-title":"J Immunol"},{"issue":"Pt 3","key":"10.1016\/j.metabol.2021.154801_bb0180","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj3480591","article-title":"Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB","volume":"348","author":"Nagarajan","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2021.154801_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molmet.2018.01.009","article-title":"Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene","volume":"9","author":"Russo","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2021.154801_bb0190","article-title":"Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles","volume":"4","author":"Mahmoud","year":"2016","journal-title":"Phys Rep"},{"key":"10.1016\/j.metabol.2021.154801_bb0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20080476","article-title":"Regulation of hypoxia-inducible factor-1alpha by NF-kappaB","volume":"412","author":"van Uden","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2021.154801_bb0200","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/sj.onc.1208516","article-title":"The oncogene PDGF-B provides a key switch from cell death to survival induced by TNF","volume":"24","author":"Au","year":"2005","journal-title":"Oncogene."},{"key":"10.1016\/j.metabol.2021.154801_bb0205","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cmet.2016.04.022","article-title":"Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production","volume":"23","author":"Titchenell","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154801_bb0210","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1053\/j.gastro.2008.08.007","article-title":"Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice","volume":"135","author":"Lee","year":"2008","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2021.154801_bb0215","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1080\/15548627.2020.1770979","article-title":"LC3-associated phagocytosis in myeloid cells, a fireman that restrains inflammation and liver fibrosis, via immunoreceptor inhibitory signaling","volume":"16","author":"Wan","year":"2020","journal-title":"Autophagy."},{"key":"10.1016\/j.metabol.2021.154801_bb0220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2021.154801_bb0225","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1572-0241.2007.01709.x","article-title":"Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment","volume":"103","author":"Carter-Kent","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2021.154801_bb0230","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2021.154801_bb0235","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/diabetes.52.3.838","article-title":"Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes","volume":"52","author":"Yokota","year":"2003","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154801_bb0240","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2021.154801_bb0245","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2015.00116","article-title":"Hepatic CEACAM1 over-expression protects against diet-induced fibrosis and inflammation in white adipose tissue","volume":"6","author":"Lester","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2021.154801_bb0250","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1172\/JCI133142","article-title":"Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury","volume":"130","author":"Nakamura","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154801_bb0255","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.28960","article-title":"Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: new evidence, new challenges","volume":"65","author":"Musso","year":"2017","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154801_bb0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep4.1117","article-title":"Exenatide induces carcinoembryonic antigen-related cell adhesion molecule 1 expression to prevent hepatic steatosis","volume":"2","author":"Ghadieh","year":"2018","journal-title":"Int Hepatol Commun"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:27:10Z","timestamp":1758428830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":52,"alternative-id":["S0026049521001013"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154801","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154801"}}